https://www.biotecheast.com/2017/04/11/lin-bioscience-licenses-cancer-drug-candidate-from-the-university-of-sydney-2/2017-04-11T14:35:54+08:00https://www.biotecheast.com/2017/04/12/economics-ministry-to-boost-medical-equipment-industry-with-nt2-bil-investment-2/2017-04-12T15:25:49+08:00https://www.biotecheast.com/2017/04/13/hiv-test-kits-can-be-picked-up-in-taiwan-chain-stores-2/2017-04-13T15:26:33+08:00https://www.biotecheast.com/2017/04/14/us-pharma-lobby-group-pushes-for-better-ip-protection-in-taiwan/2017-04-14T10:50:06+08:00https://www.biotecheast.com/2017/04/19/corning-vp-in-taiwan-for-meetings-with-itri-on-3d-cell-technology-2/2017-04-19T21:13:26+08:00https://www.biotecheast.com/2017/04/21/gntbm-to-begin-phase-iii-clinical-trial-in-taiwan-of-chidamide-for-breast-cancer-2/2017-04-21T14:03:05+08:00https://www.biotecheast.com/2017/04/26/taiwan-eyes-opportunities-in-precision-medicine-industry/2017-04-26T10:56:23+08:00https://www.biotecheast.com/2017/04/28/united-biopharma-selects-ges-flexfactory-for-new-taiwan-facility/2017-04-28T16:00:08+08:00https://www.biotecheast.com/2017/05/04/virologist-michael-lai-recognized-for-contributions-during-sars-crisis-2/2017-05-04T15:23:16+08:00https://www.biotecheast.com/2017/06/06/taiwan-a-great-location-for-biotech-ipos-says-aslan-pharma-ceo/2017-06-06T20:19:11+08:00https://www.biotecheast.com/2017/06/06/taiwan-can-become-a-regional-biotech-hub-says-vice-president-chen-2/2017-06-06T20:39:26+08:00https://www.biotecheast.com/2017/06/06/obi-pharma-announces-acquisition-of-cancer-drug-candidate-from-threshold-pharmaceuticals-2/2017-06-06T20:51:44+08:00https://www.biotecheast.com/2017/06/22/lumosa-therapeutics-lt3001-for-stroke-receives-fda-approval-to-begin-clinical-trials-2/2017-06-22T13:04:38+08:00https://www.biotecheast.com/2017/06/26/aop-orphan-and-pharmaessentia-announce-latest-clinical-results-for-ropeginterferon-alfa-2b-in-polycythemia-vera-2/2017-06-26T12:38:22+08:00https://www.biotecheast.com/2017/07/04/taiwan-joins-forces-with-insilico-medicine-to-apply-ai-to-biomedical-research-2/2017-07-04T15:24:17+08:00https://www.biotecheast.com/2017/07/14/obi-pharma-signs-agreement-with-abzena-for-adc-linker-technology-2/2017-07-14T16:43:12+08:00https://www.biotecheast.com/2017/09/07/lumosa-therapeutics-partners-with-camargo-pharmaceutical-services-for-the-development-of-its-analgesic-in-the-us-2/2017-09-07T15:03:51+08:00https://www.biotecheast.com/2018/10/02/clinical-trial-partnerships-with-australia-a-us-pharmaceutical-firm-case-study-2/2018-10-02T17:33:42+08:00https://www.biotecheast.com/2026/09/03/taiwans-lotus-pharma-inks-biosimilars-agreement-with-alvotech-for-us-and-selected-asian-markets-2/2026-09-04T16:57:47+08:00https://www.biotecheast.com/2026/09/07/formosa-pharmaceuticals-files-clinical-trial-application-for-tsy-110-an-antibody-drug-conjugate-biosimilar-targeting-her2-positive-breast-cancers-2/2026-09-07T13:46:58+08:00https://www.biotecheast.com/2026/09/08/ntu-finds-glp-1-drugs-slash-cancer-risk-2/2026-09-08T14:11:35+08:00https://www.biotecheast.com/2026/09/09/after-the-ai-rush-taiwans-biotech-stocks-want-their-turn-2/2026-09-09T12:44:50+08:00